With the return of routine Mo-99/Tc-99 generator deliveries still at least four months away, nuclear imagers are discovering clinical alternatives from old and new diagnostic protocols to keep their practices alive.
With the return of routine Mo-99/Tc-99 generator deliveries still at least four months away, nuclear imagers are discovering clinical alternatives from old and new diagnostic protocols to keep their practices alive. An online survey by the SNM and the National Association of Nuclear Pharmacies (NANP) has found the shutdown of the National Research Universal Reactor at Chalk River, ON, has disrupted 60% of radiopharmacies in the U.S.
Despite the shortage, about 40% of respondents said they have been able to fill more than half of client prescriptions for Tc-99m during the shortage. Only 6% said they were able to fill less than 25% of prescriptions.
The e-mail survey, jointly sponsored in August by the two societies, is somewhat difficult to interpret because nonresponse to questions was not recorded. But data collected from 710 SNM and 97 NANP members suggests that many nuclear imagers and radiopharmacists have been forced to make major clinical adjustments because of the supply crisis.
About one-third of respondents said they do not have access to alternative sources of Tc-99m generators, while 30% said they did have an alternative source. The alternative source appeared to be manufacturers with access to isotopes produced in reactors outside of North America.
Other findings include:
Though clinically acceptable results can be obtained with alternative isotopes, the reports of procedural delays are troubling to Dr. Michael M. Graham, SNM president.
"Getting information early in the disease progression is critical, and is one of the real benefits of molecular imaging (a term referring to imaging that measures physiological processes)," he said in a news release.
The 51-year-old NRU reactor, operated by Atomic Energy Canada Ltd., was shut down May 14 after heavy water was found leaking outside the containment vessel. Inspectors found corrosion requiring repair at several locations on the vessel. Isotope production is not expected to resume until repairs are completed in late February 2010, according to AECL.
What a New Meta-Analysis Reveals About Fractional Flow Reserve Assessment with Computed Tomography
May 13th 2024While acknowledging variable accuracy overall with CT-derived fractional flow reserve (FFR-CT) values, researchers found that the accuracy rate increased to 90 percent for FFR-CT values greater > 0.90 and < 0.49.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can a CT-Based Radiomics Model Bolster Detection of Malignant Thyroid Nodules?
May 3rd 2024A computed tomography (CT)-based radiomics model that includes 28 radiomic features showed significantly higher accuracy, sensitivity, and specificity than conventional CT in differentiating benign and malignant thyroid nodules, according to newly published research.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.